Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study-Reference-Cited by-同舟云学术

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

Published:2015-05 Issue:5 Volume:16 Page:499-508
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tabernero Josep,Yoshino Takayuki,Cohn Allen Lee,Obermannova Radka,Bodoky Gyorgy,Garcia-Carbonero Rocio,Ciuleanu Tudor-Eliade,Portnoy David C,Van Cutsem Eric,Grothey Axel,Prausová Jana,Garcia-Alfonso Pilar,Yamazaki Kentaro,Clingan Philip R,Lonardi Sara,Kim Tae Won,Simms Lorinda,Chang Shao-Chun,Nasroulah Federico

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014

2. Vascular endothelial growth factor is a secreted angiogenic mitogen;Leung;Science,1989

3. Vascular endothelial growth factor;Ferrara;Trends Cardiovasc Med,1993

4. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine;Brown;EXS,1997

Cited by 784 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells;International Immunopharmacology;2024-11

2. Colorectal cancer: Recent advances in management and treatment;World Journal of Clinical Oncology;2024-09-24

3. Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer;International Journal of Molecular Sciences;2024-09-12

4. TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial;British Journal of Cancer;2024-09-07

5. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30